Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayad Al-Katib

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Molecular Cancer|February 16, 2008
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma modelAlan A Arnold, Amro Aboukameel, Jianyong Chen, et al.
Haematologica|February 14, 2013
Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomasAsfar S Azmi, Ayad Al-Katib, Amro Aboukameel, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 18, 2011
Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disordersKaram M Obeid, Javier Aguilar, Susan Szpunar, et al.
Nuclear Medicine and Biology|April 13, 2016
Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community settingTarik Hadid, Ali Raufi, Zyad Kafri, et al.
Molecular Cancer|September 3, 2010
I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphomaAyad Al-Katib, Alan A Arnold, Amro Aboukameel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1Ramzi M Mohammad, Anton Scott Goustin, Amro Aboukameel, et al.
Leukemia & Lymphoma|September 17, 2004
Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphomaDina Ibrahim, Mitchell R Smith, Mary Varterasian, et al.
Oncotarget|November 5, 2016
Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3)Mohamed Amessou, Abdul Shukkur Ebrahim, Ashok Dilly, et al.
Cancer Biology & Therapy|September 5, 2008
Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivoYuan Sun, Jack Wu, Amro Aboukameel, et al.
Seminars in Oncology|April 30, 2003
Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaRoger G Owen, Steven P Treon, Ayad Al-Katib, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Cancer|February 16, 2008
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma modelAlan A Arnold, Amro Aboukameel, Jianyong Chen, et al.
Haematologica|February 14, 2013
Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomasAsfar S Azmi, Ayad Al-Katib, Amro Aboukameel, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 18, 2011
Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disordersKaram M Obeid, Javier Aguilar, Susan Szpunar, et al.
Nuclear Medicine and Biology|April 13, 2016
Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community settingTarik Hadid, Ali Raufi, Zyad Kafri, et al.
Molecular Cancer|September 3, 2010
I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphomaAyad Al-Katib, Alan A Arnold, Amro Aboukameel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1Ramzi M Mohammad, Anton Scott Goustin, Amro Aboukameel, et al.
Leukemia & Lymphoma|September 17, 2004
Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphomaDina Ibrahim, Mitchell R Smith, Mary Varterasian, et al.
Oncotarget|November 5, 2016
Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3)Mohamed Amessou, Abdul Shukkur Ebrahim, Ashok Dilly, et al.
Cancer Biology & Therapy|September 5, 2008
Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivoYuan Sun, Jack Wu, Amro Aboukameel, et al.
Seminars in Oncology|April 30, 2003
Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaRoger G Owen, Steven P Treon, Ayad Al-Katib, et al.
Pageof 4